echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Study of Nervous System > NEJM: Endovascular therapy combined with thrombolysis in patients with massive acute stroke

    NEJM: Endovascular therapy combined with thrombolysis in patients with massive acute stroke

    • Last Update: 2022-04-24
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Endovascular therapy has become one of the standard treatments for acute stroke
    .


    Guidelines suggest that endovascular therapy should be considered when the M1 main trunk of the cerebral or internal carotid arteries is occluded and imaging shows a moderate infarct size (ASPECTS score of 6 or more) or a volume mismatch between the ischemic core volume and the area of ​​delayed perfusion


    Vascular Stroke Guidelines Recently, researchers examined the clinical effects of endovascular therapy combined with usual care in patients with large infarcts


    The study was carried out in Japan, and patients with cerebral vascular occlusion stroke with an ASPECTS score of 3 to 5 on early CT assessment participated in the study.
    All patients were randomized to receive endovascular treatment or control on the basis of alteplase (0.
    6 mg/Kg) treatment
    .


    The primary endpoint of the study was the proportion of patients with a 90-day modified Rankin score of 0-3, and a secondary endpoint was the proportion of patients with an improved 90-day modified Rankin score of at least 8 points at 48 hours


    203 patients participated in the study, including 101 in the endovascular treatment group and 102 in the control group, and 27% of patients in each group received alteplase
    .


    31.


    31.


    90-day modified Rankin score between groups

    Between-group 90-day modified Rankin score Between-group 90-day modified Rankin score

    The endovascular treatment group had a higher proportion of patients with a better 90-day modified Rankin score
    .


    The 48-hour NIHSS scores improved in 31.


    Differences in clinical endpoint outcomes between groups

    Differences in clinical endpoint outcomes between groups

    Studies have shown that thrombolysis combined with endovascular therapy for acute stroke patients with large infarct size is better than thrombolysis alone, but the risk of intracranial hemorrhage increases
    .

    For acute stroke patients with large vessel occlusion with large infarct size, thrombolysis combined with endovascular therapy is more effective than thrombolysis alone in improving the prognosis of patients, but the risk of intracranial hemorrhage is increased
    .


    For acute stroke patients with large vessel occlusion with large infarct size, thrombolysis combined with endovascular therapy is more effective than thrombolysis alone in improving the prognosis of patients, but the risk of intracranial hemorrhage is increased


    Original source:

    Shinichi Yoshimura et al.


    Endovascular Therapy for Acute Stroke with a Large Ischemic Region.
    Leave a Comment
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.